Sep 26, 2025
Endometriosis is a chronic and often debilitating condition where tissue similar to the lining of the uterus, known as the endometrium, grows outside the uterus. This tissue can be found on organs such as the ovaries, fallopian tubes, and the pelvic lining, leading to a range of distressing symptoms. Commonly refer...
Read More...
Jul 25, 2018
The FDA has approved AbbVie's Gonadotropin-Releasing Hormone (GnRH) antagonist Elagolix on Tuesday. FDA has given green light to the first oral treatment for endometriosis pain. The drug is branded as Orilissa, and is expected to be available in U.S. pharmacies in August. It will carry a list price of about $850 per...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper